Abstract:Background Metaplastic breast carcinoma is a rare aggressive malignant neoplasm. The purposes of this study are to review the pathologic features and clinical outcomes of metaplastic breast carcinoma compared to invasive ductal carcinoma and to evaluate the prognosis of metaplastic breast carcinoma. Methods The cases of 55 patients with metaplastic breast carcinomapresenting between 1991 and 2006 were analyzed and compared to the cases of 767 age-matched patients with invasive ductal carcinoma from the same time period. Results The group of patients with metaplastic breast carcinoma presented with a larger tumor size, lower lymph node involvement, higher percentage of triple-negative (estrogen receptor-, progesterone receptor- and human epidermal growth factor receptor-2-negative) cases, and Ki-67 over-expression compared with the group of patients with invasive ductal carcinoma and triple-negative invasive ductal carcinomas. Patients in the metaplastic breast carcinoma group tended to have more local (often chest wall) recurrences ( P = 0.038) and distant (often lung) metastases ( P = 0.001) than those in the invasive ductal carcinomas group. The prognosis of metaplastic breast carcinoma was poorer than that of invasive ductal carcinoma and triple-negative invasive ductal carcinomas; the 5-year overall survival rate was 54.5% in metaplastic breast carcinoma versus 85.1% in invasive ductal carcinoma, and 73.3% in triple-negative invasive ductal carcinomas ( P <0.001). The 5-year disease-free survival rate was 45.5% in metaplastic breast carcinoma versus 71.2% in invasive ductal carcinoma, and 60.3% in triple-negative invasive ductal carcinomas ( P <0.001). Multivariate analysis revealed tumor size larger than 5.0 cm, lymph node involvement and Ki-67≥14% were significantly related to 5-year overall survival ( P = 0.010; P = 0.010; P = 0.035) and 5-year disease-free survival ( P = 0.020; P = 0.018; P = 0.049). Conclusions Metaplastic breast carcinoma shows a poorer prognosis than both invasive ductal carcinoma and triple-negative invasive ductal carcinomas. Tumor size larger than 5.0 cm, lymph node involvement and Ki-67 ≥14% indicate a poor prognosis in patients with metaplastic breast carcinoma.

Comparative Prognostic Analysis for Triple-Negative Breast Cancer with Metaplastic and Invasive Ductal Carcinoma

Difference in Characteristics and Outcomes Between Medullary Breast Carcinoma and Invasive Ductal Carcinoma: a Population Based Study from SEER 18 Database

Competing Risk Analyses of Medullary Carcinoma of Breast in Comparison to Infiltrating Ductal Carcinoma

Impact of Histotypes on Preferential Organ-Specific Metastasis in Triple-Negative Breast Cancer

The longitudinal risk of mortality between invasive ductal carcinoma and metaplastic breast carcinoma

Clinicopathologic features and prognoses of different histologic types of triple-negative breast cancer: A large population-based analysis.

The Clinicopathological Features and Survival Outcomes of Different Histological Subtypes in Triple-negative Breast Cancer

Nomogram for Predicting Survival in Triple-Negative Breast Cancer Patients with Histology of Infiltrating Duct Carcinoma: a Population-Based Study.

The clinical features and prognosis of patients with mucinous breast carcinoma compared with those with infiltrating ductal carcinoma: a population-based study

Prognosis in Triple‐negative Apocrine Carcinomas of the Breast: A Population‐based Study

Clinical Characteristics And Prognostic Analysis Of Triple-Negative Breast Cancer Patients

Unique Clinicopathological Features of Metaplastic Breast Carcinoma Compared with Invasive Ductal Carcinoma and Poor Prognostic Indicators

Chemotherapy is of prognostic significance to metaplastic breast cancer

Outcomes of Metaplastic Breast Cancer Versus Triple-Negative Breast Cancer: A Propensity Score Matching Analysis

Analysis of clinicopathological characteristics and prognosis for triple negative breast cancer

Clinicopathologic characteristics at diagnosis and the survival of patients with medullary breast carcinoma in China: a comparison with infiltrating ductal carcinoma-not otherwise specified

Sonographic and Clinicopathologic Features of Metaplastic Breast Carcinoma and Infiltrating Ductal Carcinoma: a Comparative Single-Center Cohort Study.

Clinicopathological features and prognostic factors associated with metaplastic carcinoma of the breast

Analysis of the Clinicopathological Characteristics and Prognosis of Triple-Positive Breast Cancer and HER2-positive Breast Cancer—a Retrospective Study

Comparison of Survival Outcomes in Medullary Carcinoma and Invasive Ductal Carcinoma of the Breast

Histo- and Clinico-Pathological Analysis of a Large Series of Triple-Negative Breast Cancer in a Single Center in China: Evidences on Necessity of Histological Subtyping and Grading